Overview
Skin Prick Test is a simple, reliable, and cost-effective in-vivo test used for the detection of immediate type I hypersensitivity reactions. It is considered the gold standard test for identifying IgE-mediated allergic disorders. The test works on the principle of mast cell degranulation following exposure to a specific allergen. When a standardized allergen extract is introduced into the epidermis, it binds to allergen-specific IgE present on mast cells, leading to the release of histamine and other mediators. This results in a wheal and flare reaction that appears within 15 to 20 minutes. Skin Prick Test is widely used in the diagnosis of allergic rhinitis, bronchial asthma, urticaria, atopic dermatitis, food allergy, drug allergy, latex allergy, insect venom allergy, and occupational allergies.
Symptoms
Skin Prick Test is performed in patients who present with symptoms suggestive of allergic disease. These symptoms include recurrent sneezing, nasal congestion, watery nasal discharge, itchy eyes, wheezing, breathlessness, recurrent cough, skin itching, urticaria, eczema, swelling after food intake, or reactions following drug exposure. Patients with insect venom allergy may report localized swelling or systemic reactions after stings. Although the test itself does not diagnose symptoms, it helps correlate clinical symptoms with specific allergen sensitization.
Causes
A positive Skin Prick Test reaction occurs due to IgE-mediated hypersensitivity to specific allergens. Common causative allergens include inhalant allergens such as dust mites, pollens, molds, and animal dander, food allergens such as milk, egg, peanut, seafood, wheat, and soy, and occupational allergens such as latex and chemicals. On exposure, allergens cross-link IgE molecules on mast cells, triggering degranulation and release of histamine, which causes vasodilation, increased vascular permeability, and sensory nerve stimulation, resulting in wheal and flare formation.
Risk Factors
Individuals with a personal or family history of allergic diseases are at higher risk of positive Skin Prick Test results. Patients with allergic rhinitis, bronchial asthma, atopic dermatitis, or food allergy are commonly sensitized to one or more allergens. Environmental exposure to allergens, occupational exposure, and regional allergen prevalence influence test outcomes. Factors such as recent antihistamine use, systemic corticosteroids, beta-blockers, extensive skin disease, severe dermatographism, uncontrolled asthma, pregnancy, history of anaphylaxis, and age below six months may interfere with testing or increase risk.
Prevention
Prevention in the context of Skin Prick Test focuses on safe testing practices and allergen avoidance after identification. Proper pre-test preparation, including stopping antihistamines 48 to 72 hours before testing, improves accuracy. Performing the test under medical supervision with emergency drugs readily available reduces the risk of adverse reactions. Once specific allergens are identified, preventive strategies include allergen avoidance, environmental control measures, patient education, and consideration of allergen-specific immunotherapy. Early identification of triggers helps prevent recurrent allergic symptoms and reduces trial-and-error treatment approaches.
